Pei-Ran Ho

Pei-Ran Ho

Bluebird Bio - / United States
Others
AD Scientific Index ID: 4979931
person_outline Pei-Ran Ho's MOST POPULAR ARTICLES
1-) Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open …R Kapoor, PR Ho, N Campbell, I Chang, A Deykin, F Forrestal, N Lucas, ...The Lancet Neurology 17 (5), 405-415, 20182572018
2-) Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studiesPR Ho, H Koendgen, N Campbell, B Haddock, S Richman, IH ChangThe Lancet Neurology 16 (11), 925-933, 20172562017
3-) Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosingLZ Ryerson, J Foley, IH Chang, I Kister, G Cutter, RR Metzger, ...Neurology 93 (15), e1452-e1462, 20191932019
4-) Discontinuation of denosumab and associated fracture incidence: analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) trialJP Brown, C Roux, O Törring, PR Ho, JE Beck Jensen, N Gilchrist, ...Journal of Bone and Mineral Research 28 (4), 746-752, 20131892013
5-) Automation of the kidney function prediction and classification through ultrasound-based kidney imaging using deep learningCC Kuo, CM Chang, KT Liu, WK Lin, HY Chiang, CW Chung, MR Ho, ...NPJ digital medicine 2 (1), 29, 2019